Načítá se...

Profile of gantenerumab and its potential in the treatment of Alzheimer’s disease [Corrigendum]

Novakovic D, Feligioni M, Scaccianoce S, et al. Drug Des Devel Ther. 2013;7:1359–1364.On page 1362, left hand column, last sentence under Functional studies:The effects of gantenerumab on cognitive assessment in the Morris water maze test were inconclusive, as both wild-type and transgenic...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Novakovic D, Feligioni M, Scaccianoce S, Caruso A, Piccinin S, Schepisi C, Errico F, Mercuri NB, Nicoletti F, Nisticò R
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2014-05-01
Edice:Drug Design, Development and Therapy
On-line přístup:http://www.dovepress.com/corrigendum-profile-of-gantenerumab-and-its-potential-in-the-trea-peer-reviewed-article-DDDT
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!